NAD-Na CAS 20111-18-6
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
20111-18-6
Name
NAD-Na
Synonyms
5′-ester with 3-(aminocarbonyl)-1-b-D-ribofuranosylpyridinium, inner salt, monosodiumsalt (9CI)
Adenosine5′-(trihydrogen diphosphate), P’®
Coenzyme 1
Cozymase
diphosphopyridine nucleotide
DPN
β-DPN
β-NAD
MFCD00148917
NAd
nadide
NADIDE SODIUM
UNII-B1N53L892B
β-Nicotinamide adenine dinucleotide sodium
β-Nicotinamide adenine dinucleotide sodium salt from Saccharomyces cerevisiae
Molecular Structure
SMILES
c1cc(c[n+](c1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N.[Na+]
StdInChI
InChI=1S/C21H27N7O14P2.Na/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33;/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37);/q;+1/p-1/t10-,11-,13-,14-,15-,16-,20-,21-;/m1./s1
StdInChIKey
OGCURMAMSJFXSG-QYZPTAICSA-M
Molecular Formula
C21H26N7NaO14P2
Molecular Weight
685.41
MDL Number
MFCD00148917
Properties
Appearance
White powder
Safety Data
Symbol
Signal Word
Warning
Hazard Statements
Precautionary Statements
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
WGK Germany
3
Specifications and Other Information of Our NAD-Na CAS 20111-18-6
Standard
Enterprise standard
Identification Methods
HNMR/HPLC
Purity
95%min
Sodium contents
2.6%
Water
8.0%max
PH
4.0-6.0
Storage
Keep dry and away from light, long term storage at -25℃ to -15℃
Application
It is a lot of oxidoreductase coenzyme incorporation of biocatalytic reactions by electron gains and losses.
General View of Documents
Links
Ulcho Biochemical Ltd
This product is developed by our sub R&D company Ulcho Biochemical Ltd, and please click the link below for details.
http://www.ulcho.com/nad-na-cas-20111-18-6/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/nad-na-cas-20111-18-6/